Surat, July 2022: Anupam Rasayan India Ltd. (BSE- 543275, NSE- ANURAS, ISIN: INE930P01018), one of India’s leading custom synthesis and specialty chemical player, has announced its financial results for the quarter ended June 30, 2022.
Financial Highlights for Quarter Ended June 30th , 2022:
▪ Operating Revenues at ₹3,066 million in Q1FY23 as compared to ₹2,337 million in Q1FY22 – growth of 31% Y-o-Y.
▪ Total Revenues at ₹2,971 million in Q1FY23 as compared to ₹2,380 million in Q1FY22 – growth of 25% Y-o-Y.
▪ EBITDA (incl. other revenue) at ₹845 million in Q1FY23 as compared to ₹650 million in Q1FY22 – growth of 30% Y-o-Y.
▪ Profit After Tax at ₹397 million in Q1FY23 as compared to ₹321 million in Q1FY22 – growth of 24% Y-o-Y.
Anand Desai, Managing Director of Anupam Rasayan, commented, “I am happy to inform you that, we delivered robust growth in Q1FY23 against the backdrop of an uncertain global environment. Our operating revenue grew by 31% on a year-on-year basis. Our focus on financial prudence and operational finesse has helped us keep our margins at sustainable levels. During the last financial year, our ability to ensure continuous supply to our customers has resulted in customers revising their volume guidance upwards for the current financial year along with the increase in price of these products.
Tanfac integration is progressing smoothly with the successful integration of key areas like Finance, IT, and HR and I am happy to share that we have successfully expanded the capacity of certain Tanfac products with process improvement and debottlenecking.
Overall, I believe we have an exciting year ahead of us and we at Anupam are all geared up to deliver strong sustainable growth in FY23.”
